Arkolith/Insider Trading/BICX/Form 4

Emry Kent

DirectorBioCorRx Inc. (BICX) · full profile →Form 4 · filed Jul 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2023Grant(A)3K—$0111K
Mar 31, 2023Grant(A)3K—$0108K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-23-005021) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML